Tg Therapeutics (TGTX) Enterprise Value (2011 - 2026)
Tg Therapeutics (TGTX) posted Enterprise Value of $7.8 billion for Q2 2026, up 44.2% from $5.41 billion a year earlier and up 72.8% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Enterprise Value (2011 - 2026) Analysis & Trends
For FY2025, Tg Therapeutics' Enterprise Value came in at $4.43 billion, up 1.2% from FY2024.
- Annual Enterprise Value has increased for three consecutive years, though with a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
- In prior years, Tg Therapeutics' Enterprise Value was $4.38 billion in FY2024 (+84.9%), $2.37 billion in FY2023 (+52.1%), $1.56 billion in FY2022 (-34.3%) and $2.37 billion in FY2021 (-56.0%).
- The Q2 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q2 2011.
- On a year-over-year basis, Enterprise Value increased in seven of the last eight quarters, with growth averaging 85.0%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2023, with growth of 835.9%; the weakest was Q2 2022, with a decline of 92.4%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $4.51 billion (Q1 2026), $4.43 billion (Q4 2025) and $5.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.80 Bn |
| Mar 31, 2026 | 4.51 Bn |
| Dec 31, 2025 | 4.43 Bn |
| Sep 30, 2025 | 5.43 Bn |
| Jun 30, 2025 | 5.41 Bn |
| Mar 31, 2025 | 5.96 Bn |
| Dec 31, 2024 | 4.38 Bn |
| Sep 30, 2024 | 3.30 Bn |
| Jun 30, 2024 | 2.54 Bn |
| Mar 31, 2024 | 2.14 Bn |
| Dec 31, 2023 | 2.37 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 3.60 Bn |
| Mar 31, 2023 | 2.11 Bn |
| Dec 31, 2022 | 1.56 Bn |
| Sep 30, 2022 | 662.82 Mn |
| Jun 30, 2022 | 385.12 Mn |
| Mar 31, 2022 | 1.09 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 4.38 Bn |
API Access
Tg Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();